Ambrisentan-Mepha 5 mg
Ambrisentan-Mepha 5 mg is a medicine authorised by Swissmedic under authorisation number 67294. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 27 October 2020 and the authorisation is valid without a time limit. ATC code C02KX02 places the medicine in the group Antihypertensives.
| Authorisation number | 67294 |
|---|---|
| Name | Ambrisentan-Mepha 5 mg |
| Full name | Ambrisentan-Mepha 5 mg, Filmtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C02KX02 |
| First authorisation | 27 October 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ambrisentan-Mepha 5 mg, Filmtabletten | B | 27 October 2020 |
| 2 | Ambrisentan-Mepha 10 mg, Filmtabletten | B | 27 October 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | C02KX02 | 02.07.1. | B |
| 2 | 30 | Tablette(n) | C02KX02 | 02.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Ambrisentan-Mepha 5 mg authorised in Switzerland?
Yes. Ambrisentan-Mepha 5 mg is authorised by Swissmedic under authorisation number 67294, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Ambrisentan-Mepha 5 mg have?
Ambrisentan-Mepha 5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Ambrisentan-Mepha 5 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.